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 Acute kidney injury (AKI) is defi ned by a 
rapid loss of kidney function, and it is also 
associated with kidney cell death. In ani-
mal models of AKI the morphology is pre-
dominantly characterized as necrosis, and 
acute tubular necrosis is associated with 
human AKI arising from several causes. 
However, most extensively studied  in vitro 
models of AKI, such as cisplatin exposure, 
result in apoptosis rather than necrosis. 1 
The morphologic differences between 
these two types of cell death were first 
described in 1972 by Kerr  et al. 2 Subse-
quently, apoptosis was characterized as 
 ‘ programmed, ’ and biochemical pathways 
resulting in apoptotic cell death were delin-
eated; 3 necrosis was assumed to be  ‘ acci-
dental ’ rather than the result of defi ned 
pathways. Evidence was emerging that 
depending on the stimulus, apoptosis 
and necrosis represented a continuum of 
cell-death morphologies, 4 and recently, 
unique biochemical pathways of necrosis 
were elucidated. 5,6 A type of programmed 
necrotic cell death, initially found to be 
the result of stimulation of cell-death 
receptors such as Fas, was given the name 
 ‘ necroptosis ’ and required the activity of 
receptor-interacting protein kinase 1 (RIP1 
kinase), a novel protein kinase. 7 Similarly, 
a programmed necrosis pathway inde-
pendent of cell-death receptor activation 
can be initiated by the assembly of a hetero-
multimeric protein scaffold of 2  MDa 
in the cytosol, termed the  ‘ ripoptosome. ’ 8 
The protein complexes found in these 
pathways contain RIP1 and require its 
kinase activity but can result in either 
apoptosis or necrosis. The decision to 
engage the necrosis pathway was found to 
be dependent on the kinase activity of 
another enzyme, RIP3. 
 RIP kinase activity is associated with the 
pathogenesis of several diseases, including 
brain ischemia, head trauma, myocardial 
infarction, neuronal cell death, cerulein-
induced pancreatitis, and viral infections, 
and it plays a role in lipopolysaccharide-
induced cell death. 9 RIP1 knockout mice 
die at 1 – 3 days after birth and display 
extensive apoptosis in their lymphoid and 
adipose tissue, indicating that this kinase 
is also important during development. 10 
Linkermann  et al. 11 (this issue) present 
evidence that RIP1 kinase activity also 
contributes to the damage in a mouse 
model of renal ischemia / reperfusion (I / R). 
Administration of the drug necrostatin-1, 
a specifi c RIP1 kinase inhibitor, 7 reduced 
kidney damage and attenuated AKI aft er 
I / R. A necrostatin derivative that was 
not able to inactivate the kinase activity 
had no eff ect on AKI. Signifi cantly, they 
also found that treating mice with the 
pan-caspase inhibitor zVAD-fmk did not 
prevent kidney damage and did not reduce 
I / R-induced elevations of serum creati-
nine or urea, and did not reduce renal cell 
death. Electron microscopic examination 
of kidney tissue aft er I / R showed typical 
hallmarks of necrotic but not apoptotic 
cell death. However, other parameters that 
could have provided evidence of apopto-
sis, such as TdT-mediated dUTP nick end 
labeling (TUNEL) to detect apoptosis-
specifi c DNA damage, were not reported. 
These findings suggest that caspase-
dependent apoptosis does not play a sig-
nificant role in this setting. Similarly, 
caspase-3 knockout mice were not pro-
tected from I / R AKI (GP Kaushal (Uni-
versity of Arkansas for Medical Sciences), 
personal communication), although these 
mice were reported to be partially pro-
tected from polycystic kidney disease. 12 
Caspase-8 activation promotes cell death 
in receptor-mediated apoptosis, and cas-
pase-8 is also found in multimeric protein 
complexes in programmed necrosis path-
ways. At the same time, caspase-8 has a 
role in survival, probably by preventing 
RIP-dependent necrosis during develop-
ment, and caspase-8 knockout mice are 
not viable. 6 Whether caspase-8 is a protec-
tive protein or promotes kidney cell death 
in I / R AKI would therefore be interesting 
to study. 
 Th e best-described pathways of pro-
grammed necrosis are associated with the 
activation of death receptors ( Figure 1 ). 
Aft er ligand binding, the activated recep-
tor promotes the assembly of multimeric 
protein scaff olds ultimately containing 
caspase-8, RIP1, and RIP3. Th e activation 
of nuclear factor-  B and transcription of 
downstream proteins usually promotes 
cell survival, which paradoxically could be 
dependent on caspase-8. 6 When the 
nuclear factor-  B signal is blocked, as 
with cycloheximide addition, caspase-8 
activation predominates and apoptosis 
results. When caspase-8 is inhibited, 
as with zVAD addition, RIP3 kinase is 
activated, resulting in programmed necro-
sis, or necroptosis. Linkermann  et al. 11 
have demonstrated that necrosis resulting 
from these protein assemblies can occur 
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in cultured kidney cells, indicating that 
these pathways could also occur in the 
kidney  in vivo . Using several cell lines 
derived from kidney tissues, and inducing 
cell death by stimulating the tumor necro-
sis factor-  death receptor pathway in the 
presence of cycloheximide and zVAD-
fmk, the authors showed that glomerular 
endothelial cells were sensitive to necro-
ptosis, whereas mesangial cells and podo-
cytes were not. Cell death in a mouse 
kidney tubular cell line (TKPTS) was pro-
tected both by necrostatin-1 and by RIP1 
knock-down, but only the glomerular 
endothelial cells were protected by RIP3 
knock-down. 
 Since exposure of cultured cells to 
tumor necrosis factor-  , cycloheximide, 
and zVAD has been used to demonstrate 
the existence of the necroptosis path-
way, 8,9 it is signifi cant that several kidney 
cell types were also sensitive to these 
stimuli, showing that necroptosis could be 
a potential cell-death pathway in the 
kidney. However, it is unclear whether 
common molecular pathways are shared 
between I / R-induced renal cell death 
 in vivo and death receptor-initiated cell 
death occurring  in vitro in the presence of 
protein synthesis and caspase inhibitors. 
It is also possible that the recently 
described  ‘ ripoptosome ’ 8 participates in 
the  in vivo mechanism of I / R-induced 
kidney cell death. Th is multimeric protein 
complex assembles in the cytosol inde-
pendent of cell-death receptor activation, 
and its formation could be stimulated by 
exposure to etoposide, a DNA-damaging 
agent, or by depletion of cellular inhibitors 
of apoptosis proteins (cIAPs). Its assembly 
was dependent on RIP1, and the complex 
could induce either caspase-8-dependent 
apoptosis or RIP3 kinase-dependent 
necrosis. Th e cellular stresses promoting 
ripoptosome formation, its cell-type spe-
cifi city, and the ultimate consequences of 
its formation are still being elucidated. 
 Th e results of Linkermann  et al. 11 are 
provocative and could encourage future 
examination of programmed necrosis 
pathways in AKI. Although they provide 
suffi  cient evidence that a RIP1 kinase-
dependent pathway plays a role in renal 
I / R, the implication that necroptosis is the 
causative mechanism is not yet convinc-
ing. RIP1 kinase activity is most likely 
involved in the pathobiology, but necro-
statin-1, a RIP1 kinase-inhibitory drug, 
can also inhibit apoptosis. Cultured cells 
were made to undergo necroptosis, show-
ing that this pathway could exist in the 
kidney  in vivo , but attempts to demon-
strate by co-immunoprecipitation the 
associations of RIP1 and RIP3 kinases 
thought to be necessary for necroptosis 
were not successful. 
 It is hoped that these studies will pro-
vide the stimulus for further investigations 
on pathways of programmed necrosis in 
kidney disease, so that for AKI, to borrow 
Winston Churchill ’ s phrase, it is, perhaps, 
the end of the beginning. 
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 Figure 1  |  Stimulation of cell death pathways by extrinsic pathway. Binding of the tumor 
necrosis factor-  (TNF-  ) ligand to its receptor, TNFR1, leads to recruitment of TNF receptor-
associated death domain (TRADD). These proteins associate with other cytoplasmic proteins, 
including RIP1, TNF receptor-associated factors (TRAFs), and cellular inhibitors of apoptosis 
proteins (cIAPs), to form Complex 1. Complex 1 can also activate nuclear factor-  B (NF-  B) and 
thereby transcription of FLICE-like inhibitory protein long (FLIP). Several steps later, the RIP1-
associated complex can functionally interact with RIP3 and caspase-8, forming Complex 2. With 
high levels of FLIP, the complex does not result in RIP3 signaling, and cell death is averted. Without 
FLIP, as with cycloheximide (CHX) addition, caspase-8 activation predominates and apoptosis 
results. When caspase-8 is inhibited, as with zVAD addition, RIP3 kinase is activated, resulting in 
programmed necrosis, or necroptosis. Necrostatin-1 blocks the kinase activity of RIP1, which is 
necessary for both apoptotic and necrotic pathways directed by Complex 2. Not shown here, in a 
similar death receptor-mediated pathway, ligand binding to CD95 / Fas induces a conformational 
change in the receptor, which promotes the assembly of a complex with Fas-associated death 
domain (FADD) and caspase-8. Similarly to the TNF pathway, FLIP can prevent caspase-8 apoptosis, 
and cycloheximide addition can promote cell death. 
